Please login to the form below

Not currently logged in

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Regulatory

EMA starts review of Xtandi in non-metastatic prostate cancer

astellas headquartersThe evaluation is based on positive results from the PROSPER trial

From: Sales

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug

Lundbeck HQFoliglurax is currently in phase II testing for LID, muscle stiffness and ‘freezing’

From: Marketing

IQVIA partners with Box

IQVIAWill work on managing content for the life science industry

From: Healthcare

NHS seeks 'solution creators' from within pharma

IQVIA UK marketing accessHealth service is moving to a 'new era' of industry relations, says NHS England


Pharmaceutical Market Europe - March 2018

Pharma’s transition continues apace, as the real, game-changing innovation it creates in areas such as cancer and hepatitis sees the question of how to reward these advances become evermore pressing.

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Dominic Tyer

Have your say...

Lighthouse bolsters its US senior scientific team

Marc Pondel joins the agency as executive medical science director


'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Bayer looks to leverage AI across the pharma value chain

Dieter Weinand outlines his hopes for applying artificial intelligence

Bayer symbol

Featured jobs

Subscribe to our email news alerts


Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?